Home > News > ACLARA Receives 4 U.S. Patents
April 5th, 2004
ACLARA Receives 4 U.S. Patents
ACLARA BioSciences announced the issuance of four U.S. patents that strengthen the intellectual property around its eTag technology: Nos. 6,682,887 and No. 6,686,152 with claims related to certain eTag applications; No. 6,673,550 with broad claims related to certain specific eTag reporter molecules including assays related to protein and protein complex expression; and No. 6,685,813 with claims related to eTag sample handling in a nanofluidic setting.
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014